Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paper-Reference-Cited by-同舟云学术

Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paper

Published:2021-03-01 Issue:8 Volume:22 Page:609-617
ISSN:1558-2027
Container-title:Journal of Cardiovascular Medicine
language:en
Short-container-title:

Author:

Colivicchi Furio,Di Fusco Stefania Angela,Arca Marcello,Leggio Massimo,Caldarola Pasquale,Murrone Adriano,Valente Serafina,Urbinati Stefano,Roncon Loris,Amodeo Vincenzo,Aspromonte Nadia,Cipriani Manlio,Domenicucci Stefano,Francese Giuseppina Maura,Imazio Massimo,di Uccio Fortunato Scotto,Di Lenarda Andrea,Gulizia Michele Massimo,Gabrielli Domenico

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference64 articles.

1. The success story of LDL cholesterol lowering;Pedersen;Circ Res,2016

2. Quantifying atherogenic lipoproteins: current and future challenges in the era of personalized medicine and very low concentrations of LDL cholesterol. A consensus statement from EAS and EFLM;Langlois;Clin Chem,2018

3. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2020

4. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge;Friedewald;Clin Chem,1972

5. Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method;Whelton;J Clin Lipidol,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early-onset atherosclerotic cardiovascular disease;European Journal of Preventive Cardiology;2024-07-23

2. Dysregulated serum lipid profile and atherosclerosis in untreated female TA patients: a PSM analysis;2023-06-09

3. Lipoprotein (a), Inflammation, and Atherosclerosis;Journal of Clinical Medicine;2023-03-27

4. CYP2C19 metabolizer phenotypes may affect the efficacy of statins on lowering small dense low-density lipoprotein cholesterol of patients with coronary artery disease;Frontiers in Cardiovascular Medicine;2022-12-19

5. Age-specific association between non-HDL-C and arterial stiffness in the Chinese population;Frontiers in Cardiovascular Medicine;2022-09-26